A Bristol business has developed a pioneering next-generation mini fusion reactor with the potential to revolutionise cancer diagnosis and treatment. Co-founded by a research associate and a visiting fellow at the University of Bristol, Astral Systems has developed the first-of-its-kind multi-state fusion (MSF) reactor, not much bigger than a...